This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Mona Siddiqui, Chief Data Officer at the Department of Health and Human Services, who is overseeing a transformation in health information sharing between all agencies at HHS. She discusses the infrastructure changes required to facilitate data liquidity and growing partnerships with outside entrepreneurs to expedite the process.
This week we revisit our conversation with Dr. Lloyd Minor, Dean of the Stanford School of Medicine, on his strategic plan for advancing 21st century biomedicine. He discusses the transformation underway in health care using data, artificial intelligence and telehealth protocols to support health industry transformation, and how all of this will impact medical education in the future.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Donald Warne, Director of Indians Into Medicine (INMED) at the University of North Dakota School of Medicine and Health Sciences. He discusses the impact of cultural trauma on the American Indian population, strategies for addressing health disparities and the need to mentor Native youth in the health professions.
This week, hosts Mark Masselli and Margaret Flinter speak with Pulitzer Prize winning writer Barry Meier, author of “Pain Killer: An Empire of Deceit and the Origin of America’s Opioid Epidemic,” on Purdue Pharma, makers of the narcotic OxyContin, and the pivotal role they played in “the greatest public health crisis of the 21st Century.”
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Rasu Shrestha, Chief Innovation Officer of UPMC and VP of UPMC Enterprises, the entrepreneurial division of the University of Pittsburgh Medical Center. Dr. Shrestha is also Co-Chair of Health Datapalooza, and discusses the need for design thinking and building a culture of innovation to truly transform the health care system.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Eric Topol, renowned cardiologist, geneticist, digital health advocate, and founder of the Scripps Translational Science Institute. They discuss his work developing technologies for the “All of Us” precision medicine campaign at NIH, and the efforts still needed to support true precision medicine initiatives in American health care.